CLINICAL_TRIALS
trial_result
· 2012-09-05
Clinical Trial Update: Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery [Phase 2]
Summary
Phase 2 clinical trial evaluating erlotinib for breast cancer that can be removed by surgery has completed; results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-09-05